Checkpoint Therapeutics, Inc (CKPT): Prakiraan konsensus analis

Checkpoint Therapeutics is developing budget-friendly immunotherapy methods by optimizing development costs to compete with major brands. The business model relies on outsourcing molecule synthesis and testing to external contractors, which creates a dependency on partners, and the indicator is 4.46. This chart on GURU.Markets complements data regarding the strict control of biomaterial delivery via verified express carriers.

Checkpoint Therapeutics Inc (CKPT) - Target konsensus saka 04.07.2022 nganti 07.06.2025

Rincian analitis perusahaan Checkpoint Therapeutics, Inc (CKPT)

Indikator analitis utama Checkpoint Therapeutics Inc (CKPT):

Kutipan saham checkpointtx.com|CKPT - Bagan rega target|Kapitalisasi pasar Checkpoint Therapeutics, Inc

Analisis fundamental perusahaan:checkpointtx.com (CKPT)

Produk asli Checkpoint Therapeutics, Inc

The prospects for Checkpoint Therapeutics (CKPT) depend on FDA approval of cosibelimab and potential M&A deals, rendering the share price sensitive to the interpretation of clinical data. This indicator aggregates investment house expectations, capturing the transformation of the business's fair value during periods of uncertainty; therefore, the history of expert consensus estimates serves as a filter to avoid purchasing assets based on false market impulses.

Perusahaan pesaing

Target konsensus beigene.com ONC|Bagan rega target Halozyme HALO|Prakiraan konsensus analis Revolution Medicines Inc RVMD|AAPG - Bagan rega target|Bagan tingkat prakiraan CGON|URGN (UroGen Pharma Ltd.) - Target konsensus|BCAX: Rega prakiraan analis|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|TARA: Konsensus nilai wajar|Target konsensus FATE (Fate Therapeutics)|WHWK (aadibio.com) - Konsensus nilai wajar|Prakiraan konsensus analis TCRX (TScan Therapeutics, Inc.)|CSBR - Target konsensus|XBIT: Target konsensus|CVM - Prakiraan konsensus analis|OS Therapies (OSTX) - Bagan rega target|Radiopharm Theranostics Ltd - Konsensus nilai wajar|ARTV (Artiva Biotherapeutics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Adlai Nortye Limited ANL|Prakiraan konsensus analis VERU|Target konsensus tempesttx.com TPST|Prakiraan konsensus analis XLO (Xilio Therapeutics)|Konsensus nilai wajar RENB|Mural Bio - Prakiraan konsensus analis|Rata-rata rega prakiraan Kairos Pharma Ltd|OKUR: Prakiraan konsensus analis|Target konsensus CytoMed Therapeutics Limited|Bagan rega target Curis Inc.|Prakiraan konsensus analis Apollomics Corp|Bagan rega target Tharimmune Corp (THAR)|ADVB: Bagan tingkat prakiraan|Bagan rega target Genprex, Inc. GNPX|Calidi Biotherapeutics Inc. (CLDI) - Rata-rata rega prakiraan|Sunshine Biopharma - Prakiraan konsensus analis|Target median analis Xenetic Biosciences XBIO|Salarius (SLRX) - Bagan rega target|Prakiraan gabungan firma investasi PPBT|Target konsensus AONC|BGNE (beigene.com) - Rega prakiraan analis|Target konsensus ELEV (Elevation Oncology, Inc.)|ICAD (icadmed.com) - Konsensus nilai wajar|Ikena Oncology - Target konsensus|Rega prakiraan analis NTBL (Notable Labs Corp)|Viracta - Prakiraan konsensus analis|Konsensus nilai wajar MOR (morphosys.com)|NAYA: Prakiraan konsensus analis|Rata-rata rega prakiraan Ascentage Pharma Group International (AAPGV)